Knygos.lt nariams
21,20 €
-30%
Įprastai
30,29 €
The Billion-Dollar Molecule
Knygos.lt nariams
21,20 €
-30%
Įprastai
30,29 €
- Išsiųsime per 12–18 d.d.
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing--atom by atom--both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you…
/images/books/4068520/9780671510572.jpg)
- Autorius: Barry Werth
- Leidėjas: Simon & Schuster
- ISBN-10: 0671510576
- ISBN-13: 9780671510572
- Formatas: 14.1 x 21.3 x 3 cm, minkšti viršeliai
- Kalba: Anglų
Atsiliepimai
Aprašymas
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing--atom by atom--both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Knygos.lt nariams
21,20 €
-30%
Įprastai
30,29 €
Išsiųsime per 12–18 d.d.
- Autorius: Barry Werth
- Leidėjas: Simon & Schuster
- ISBN-10: 0671510576
- ISBN-13: 9780671510572
- Formatas: 14.1 x 21.3 x 3 cm, minkšti viršeliai
- Kalba: Anglų
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing--atom by atom--both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Atsiliepimai